HIMS is going to resume its uptrend Long
Hims & Hers Health, Inc.NYSE
Description
⋅ NYSE:HIMS is about to resume it's uptrend
HIMS broke out from stage 1 to stage 2 and ran from $7 to $12 in couple of months, since than it retraced, but seems to close the week very strong.
Look for 30% upside from here